1. Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer. (July 2018) Authors: Cavalieri, S.; Perrone, F.; Miceli, R.; Ascierto, P.A.; Locati, L.D.; Bergamini, C.; Granata, R.; Alfieri, S.; Resteghini, C.; Galbiati, D.; Busico, A.; Paielli, N.; Patuzzo, R.; Maurichi, A.; Gallino, G.; Ruggeri, R.; Mariani, L.; Palla, M.; Licitra, L.; Bossi, P. Journal: European journal of cancer Issue: Volume 97(2018) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP-1392: The abscopal effect:efficacy of radiotherapy in patients on progression after ipilimumab 3 mg/kg. (April 2016) Authors: Grimaldi, A.M.; Ascierto, P.A.; Simeone, E.; Giannarelli, D.; Falivene, S.; Borzillo, V.; Giugliano, F.; Sandomenico, F.; Petrillo, A.; Curvietto, M.; Esposito, A.; Paone, M.; Palla, M.; Palmieri, G.; Caraco, C.; Ciliberto, G.; Mozzillo, N.; Muto, P. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S649 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗